<DOC>
	<DOC>NCT00238940</DOC>
	<brief_summary>This extension study is considered to allow patients being treated with EC-MPS to collect further information on the long-term safety of this drug.</brief_summary>
	<brief_title>Extension Study of Enteric-coated Mycophenolate Sodium in Combination With Full Dose or Reduced Dose Cyclosporine Microemulsion in Patients With de Novo Kidney Transplants</brief_title>
	<detailed_description />
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>Inclusion/ Exclusion criteria All patients who completed study CERL080A2405DE01 and who are willing to continue treatment with ECMPS. Other protocoldefined inclusion/exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Renal transplantation, Enteric-Coated Mycophenolate Sodium (EC-MPS)</keyword>
</DOC>